To hear about similar clinical trials, please enter your email below
Trial Title:
Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
NCT ID:
NCT05842031
Condition:
Penile Cancer
Conditions: Official terms:
Penile Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Behavioral
Intervention name:
Quality of Life Questionnaires
Description:
Identify what interventions may be helpful in improving quality of life.
Arm group label:
Semi-structured interviews
Intervention type:
Behavioral
Intervention name:
Patient Educational Needs
Description:
Identify what interventions may be helpful in improving patient educational needs
Arm group label:
Semi-structured interviews
Intervention type:
Behavioral
Intervention name:
Symptom Management
Description:
Identify what interventions may be helpful in improving symptom management Improve
symptom management
Arm group label:
Semi-structured interviews
Summary:
To learn more about the patient experience undergoing inguinal (in the groin) lymph node
procedures for penile cancer during and after surgery.
Detailed description:
Objectives
Primary Objective:
To understand the lived experience of patients undergoing invasive inguinal lymph node
procedures.
Secondary Objective:
To determine factors that influence decisions and improve experience for patients who
need invasive inguinal lymph node procedures.
Criteria for eligibility:
Study pop:
M D Anderson Cancer Center
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
--Patients diagnosed with penile cancer who have undergone invasive inguinal node
procedures (ILND and/or DSNB) and are at least 6 months post-procedure
Exclusion Criteria:
- Patient's ≤18 years of age
- Patients who have not undergone invasive surgical procedures involving the inguinal
lymph nodes
- Non-English-speaking patients For interviews: people who are physically and/or
cognitively incapable of participating in a 60minute telephone interview as
determined by a clinical provider or the patient.
Gender:
Male
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
MD Anderson
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Curtis Pettaway, BS, MD
Phone:
(713) 792-3250
Email:
cpettawa@mdanderson.org
Start date:
April 14, 2023
Completion date:
December 31, 2026
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05842031
http://www.mdanderson.org